Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
These are the same questions I was asking JB for a long time now w/o any replies. It seems to me that he doesn't like straight questions and prefer to promise in general. Well JB as you can see looking at PPS (YES, PPS IS THE NAME OF THE GAME!)it doesn't work any more. My latest questions about a new record and pay days are still not answered.
JB, what ever your situation is you can't buy investors on promises any more. It has been too many promises w/o results.
You have to get out of your closet and start to give us progress reports and documented facts. Over wise more silly market orders will follow. YOU CAN DO IT JONATHAN! WE STILL BELIEVE IN YOU!!!
Well done Doc!!! I'm sitting deep in MDFY, so can only watch.
Nice to see you back on our board - THE BEST BOARD on Medify in pre and after split times! Did you meet Trevor there by any chance? He should be having a good time now. Well, our time is coming according to J.B.. We just have to figure out Monday/Friday stuff.
But they have to be translated in English first.(An it's coming from me.LOL)
MDFYFORLONG, I'm reposting your post # 9852:
MDFY Gains
Sincerely speaking, all this discussion board is the problem for this stock, I have been on other boards and everyone is talking about how to increase the value of their shares, either by telling others to buy the stock and explaining its business model. On this board people are more interested in a product picture, all of us who own the stock want to make money. Many of you are bidding down the stock just to get rid of the stock, while I really have no clue, if everyone put a limit order for $1.00 this would not have happened. Likewise, even in the midst of good information whether speculative or not, you guys still criticize you had destroying your own shares. Its funny even if Jonathan came and confirmed some of the rumors many of you would still criticize, look at RIMM yesterday only a few people where positioned for that gain because people did not read into the lines of speculation and company growth.
Medify Solutions is a growth company and just give it a chance, the stock in "my opinion" and those of many other shareholders is a 250 bagger. Do not sell you stock buy more.
"P.S. yes this is a new account, so do not make big deals about it"
COME ON, GIVE ME A BRAKE!!!
Sherlock
Hi Lem. Are you "back in the saddle again"?
Did anything happened in that Chicago store after giving away free bottles of e-water? Thanks.
10-bagger from here after 1:12 R/S is stll far away from the promised land. I hope you hear me J.B..
You posted everything I wanted to say.
It's a very nice product and this is what we should be talking about! GO JOHNY and MEDIFY everyone and evrywhere!!!
Don worry guys, these are Trevor's records.LOL
Doc, looking at his medical history I would say...
that he needs a drink tonight. Me too.
Good luck with your all investments.
Doc,just rounded up my new number for MDFY, if I wouldn't have enough. You can call me crazy.
Looks like I got an answer on my yeasterday's letter to JB. I just don't understand why he can't make a public annoucement.
Hi Jonathan,
If the dividend is real than why wouldn't you announce the extension of Record Day ( you don't have to give the actual day if you don't want) and the ratio to new MDFY shares?
I think it would have the positive affect on PPS right away.
Regards,
Solidgold
What a day! But tomorrow is another day. For me it's still today.
Have a good night, MF'rs!
I think extended and post split. The extension would move PPS in one day and no chances for turning back to pre split. IMHO
Bid/.43 + Ask/.50 = Sales/.40 = BS!!!
Letter from Jonathan:
Solidgold,
The pictures will be posted professionally on the website, I just felt that if the product was seen it would provide some confidence.
The issue we face is that whatever I do, and I have done a lot, believe me, the stock gets turned over and over to make money for certain individuals and not us, nor the company. I am aware that certain people are dumping their stock which is an ever draining process. So let them get out, once they are, I can build the company up again, I can reward the long shareholders based on revenue and success and then and only then we will the real supporters of the company benefit and not be manipulated.
I am working on the dividend and I will get back to you when I have the concrete answers. The dividend is absolute and will happen. What I really want is for all the non-believers (idiots as I call then politely) to get out of the deal. When this has happened and the revenues are proven, I can then reward and reconcile.
Announcements will follow but there is no point as when I put out announcements, the trades go up, more stock is sold at a lower level and so begins the cycle. So when the stock for sale is depleted and when the news is significant, then not only will the pps rise, not only will the shareholders be rewarded through dividends but I will at last be vindicated, not vilified.
Jonathan
" A rumur and some insider information has surfaced..."-We all discussed some possible buyouts, but as far as I know no "insider" participated in this. So now it's "surfaced" back to us, "insiders". LOL
Just enlarged and printed out pictures from JB and they look really nice.
The display is on Vodafone handheld unit and shows examples of communication with medical notes. Another display showes LOG ON page with Medify Solutions logo on the top.
Sorry that couldn't share with you all.
Thank you for response.
Germany could be great market for Medify. Awhile ago I send Trevor an article about problems with medical care in some remote German areas. It also could be in one of my earlier post.
Just send another e-mail to JB :
Hi Jonathan,
Thanks for response and pictures. May be you can put these pictures on co's web site?
Now, the MAJOR investors worry is R/S done w/o any positive and clear announcements following right away such as dividend record and pay dates, up listing on NASDAQ, big new contracts in UK or elsewhere. Why was such a hurry with RS? WHAT IS GOING ON WITH DIVIDEND? I hope that the only EXTRAORDINARY thing about it wasn't R/S which cut our shares and PPS so dramatically. These are the questions what investors are WAITING FOR!!!
In a mean time their confidence in the company is dropping every day together with PPS.
Still waiting for your urgent response and announcements.
Regards,
Solidgold
I got response and pictures from Jonathan,
but can't transfer pictures for you so far.
Still working on it.
Hi Jonathan,
If you read investor's board you saw today's outburst by disappointed investors. It shouldn't make you happy, and it didn't make me happy either. I'm not going to repeat the same stuff all over and over again, it's no point to this. Just wanted to ask you to take all the actions necessary to restore the investors trust in you and your company ASAP!
I do honestly believe that this should be your #1 priority right now.
With the very best wishes, yours truly,
Solidgold
-----------------------------------------------------------------
Solidgold,
Damned if I do and damned if I don't. So people want proof this is happening and real., please see attached the product working and actual and in the hands of Drs.
The next stage is revenue which is on its way as stated publicly and as posted. I cannot move this forward as it is not my gift to give as commercial we are tied to the wished of our partners.
But the evidence is there, the product is there and anyone who can hang on and take the pressure will be utterly vindicated, proven and extremely well rewarded.
Jonathan
Did you guys get your gold dividends in 5 companies? Not me.
I'm still waiting for my dividends. What can be done about it?
Thanks.
I trust jStellar and believe in company.
Solidgold
One more to read:
Why We Love Wild Penny Stocks
By Tim Hanson (TMF Mmbop) and Brian Richards (TMF Brich)
September 25, 2006
Penny stocks have huge potential -- that's their blessing and their curse.
The potential rewards are enormous. Just take a look at what's happening at Acorda Therapeutics (Nasdaq: ACOR) today -- the stock is up 240% at last check, following some positive news regarding its multiple sclerosis treatment.
That $5 triple looks like an easy gain, considering that Altria (NYSE: MO) would have to add another $80 in value to double its share price, and Goldman Sachs (NYSE: GS) would need to throw another $170 on the fire to eke out another double.
Everybody loves pennies
It's the potential of quick gains in stocks like Acorda that keeps investors coming back. We typed "penny stocks" into Google and the search engine spit out "about 2,650,000" hits. We did the same for more time-tested terms such as "blue-chip stocks" and "dividend-paying stocks" and got just 273,000 and 183,000 hits, respectively.
Sure, we expected a discrepancy, but the size of the gap was startling. It became even more interesting when we broke those hits down with Google Trends. According to Trends, penny stocks are particularly alluring to investors in Orlando, Las Vegas, Oklahoma City, Tampa, and Calgary -- the locales where the term is most often searched.
Las Vegas, for one, makes a bit of sense. Those folks are gamblers.
Florida, though? Well, we hope the folks googling "penny stocks" down there aren't retirees.
This stock is set to take off! Or not.
According to the Securities and Exchange Commission, the term "penny stock" generally refers to low-priced (below $5), speculative securities of very small companies. To quote the SEC: "Investors in penny stocks should be prepared for the possibility that they may lose their whole investment." (It's worth noting that the emphasis in that last sentence is in the original.)
Pay attention to the SEC's entire definition, not just the stock price. Going solely on price would wrongly categorize billion-dollar companies such as Finisar (Nasdaq: FNSR), Sanmina-SCI (Nasdaq: SANM), and Gemstar (Nasdaq: GMST) as penny stocks.
Regardless, the SEC is spot-on when it says that true penny stocks are among the surest ways to lose money in the stock market.
Well, then, why do we "love" penny stocks?
We love penny stocks because they're fascinating. The world of pennies is inhabited by hardworking average Joes hoping to strike it rich, pumpers and dumpers, hypesters and scammers. In pennies, the logic and reason that applies in the rest of daily life is replaced by zeal and prayer.
However, we don't love them enough to actually buy them. Yes, they have big potential. But their daily gyrations are unpredictable -- the stock price movements have next to nothing to do with the underlying company the stock represents. In fact, trading in pennies is highly illiquid, and prices are often manipulated by forces not at all related to the business.
The dangers of incredible promises
If you're buying stocks without paying attention to the business you're buying, then you might as well be buying a lottery ticket. Or (to use another analogy) you might as well buy up every baseball card of a benchwarmer on the Akron Aeros AA baseball team, and hope that he someday rises up, fulfills his potential, and becomes an all-star for the big-league Cleveland Indians.
There's a better way
Before you start saying the rest of the stock market is boring -- with big stocks such as IBM having a "big day" when they move up 1% or so -- let us introduce you to some underfollowed small caps. They're nothing like penny stocks, yet they still offer some of the best returns on the market. Unlike penny stocks, promising small caps:
file reliable financial statements
are transparent
have conference calls individual investors can listen to
don't simply hype their stock in press releases
That's a starting point. There are more -- and more important -- criteria to help you find great small-cap companies. Our team at Motley Fool Hidden Gems, for instance, looks for a balance sheet with lots of cash and no debt, and a tenured CEO (or CEO/founder, if possible) who holds a substantial ownership stake in the business. In other words, we're looking for big returns with good, old-fashioned, bottom-up analysis.
You can view the more than 50 small caps our team has already found with a free 30-day trial. There's no obligation to subscribe, and we particularly recommend it for the penny stock-o-philes reading in Alberta and Florida. You know who you are.
This article was originally published on July 27, 2006. It has been updated.
Another RS and some interesting comments:
Motley Fool
JDSU Goes Through With Reverse Split
Tuesday September 26, 11:54 am ET
By Anders Bylund
Last December, the board of JDS Uniphase (Nasdaq: JDSU - News) approved a reverse stock split in the range of 1-8 through 1-10, and management made it clear that the transaction would only take place under certain conditions. Mainly, the business would have to achieve and maintain positive non-GAAP EBITDA (earnings before interest, taxes, depreciation, and amortization) margins, a sign of stabilizing operations.
Indeed, the company appears to have reached that target and is now going ahead with the reverse split (stock merge?). On Oct. 17, any JDSU stock you own will be converted into one-eighth as many shares with the ticker JDSUD, which will then revert back to trading as JDSU about 20 trading days later. Any fractional shares that result from the switch should be paid out in cash. The price of the stock, convertible notes, and stock options will multiply by eight, and you're left with the same cash value in JDSU stock as you had the day before. Assuming that the share price at the time of writing ($2.22) holds until then, the new shares should trade around the $17.76 price point.
Stock splits are usually not newsworthy to a Fool, as they amount to changing five pennies for a nickel, or the other way around. However, there are times when a split can have real effects on a stock's performance. This is one such case.
JDSU shares have traded below the magical $5 barrier for years, making it look like a risky penny stock. Staying there for too long will endanger the company's good standing in the Nasdaq (Nasdaq: NDAQ - News) set of rules, and could result in it getting booted down to the illiquid Bulletin Board market. What's more, many trading houses, mutual funds, and the like are not allowed to touch stocks trading at prices that low, which again hurts liquidity and market visibility. Finally, the market often behaves as a giant game of mass psychology. If you see JDSU trading at $2.22, Finisar (Nasdaq: FNSR - News) at $3.67, Coherent (Nasdaq: COHR - News) at $36.42, and Oplink (Nasdaq: OPLK - News) at $19.96, which ones look like toys to you? The capacity for taking things seriously seems to increase in lockstep with its market price.
So has JDS Uniphase really turned a corner worthy of newfound respect? The early signs are there, but only time will tell for sure.
Some very interesting stuff to read (IMHO):
No mistake
19 Sep 2006
Daloni Carlisle
It's all too easy to make a 'tpying errer'. When it’s E-Health Insider it just makes us look sloppy. But when it’s a GP practice it can determine whether a doctor has access to a new patient’s notes.
An exercise to test the quality of GP lists and how well practices cope with changes of address and deaths has uncovered just how easy it is for spelling mistakes to slip through the net.
The National Duplicate Registration Initiative (NDRI), found 4,781 misspelt Micheals (compared to 799,565 correct Michaels), making them difficult to track should they move.
The NDRI also found 135,000 patients on GP lists who were, in fact, dead. Over 10,500 of these had died before 1990 and so had been on a GP list for at least 15 years before they were removed. The longest case was a patient who died in 1964 but was not removed from the GP list until 2004.
These are some of the several fascinating results of this summer’s final report of the NDRI, a massive data matching exercise which started in 2003/04 and was undertaken by the Audit Commission as part of the statutory audit of primary care trust and local health board accounts.
In brief, it involved extracting electronic details of the 56 million patients registered with GPs in England and Wales, undertaking data matching with records from, for example, the Department for Work and Pensions and the Home Office then feeding back the matches for review.
“We also used fuzzy logic that would pick up things like the misspellings,” said project manager Darren Shillington. “That’s how we picked up the Micheals as well as more unusual one-off mistakes.”
In total almost 1.5 million matches were fed back to the 87 National Health Applications and Infrastructure Services (NHAIS) sites who manage the patient list data for all PCTs and LHBs. They in turn worked with their local GP surgeries to cleanse their lists of any duplicates.
Cancelled registrations
The Audit Commission’s main concern, as one would expect, was value for money. The audit took place as the new General Medical Services Contract came into play. With payments based in part on patient numbers, the Audit Commission was keen to make sure practices had accurate records.
By and large they did. The NDRI has led to 185,000 registrations being cancelled, saving £9.5 million. A significant number, to be sure, but representing only 0.3 per cent of the population.
Or as Mr Shillington puts it: “From our perspective we were looking for audit assurance. Is the data reliable and materially accurate? We got considerable assurance about the accuracy of payments being made on the basis of the data. Yes there are anomalies but we found that the system is solid.”
The NDRI highlighted the difference between NHAIS sites responding to the exercise. Each participant received a CD-ROM with matches that needed examining and while the Audit Commission provided guidance, each responded in its own way.
For example, Essex NHAIS sites automated a validation of 4,242 deceased persons’ matches by using Microsoft Access to compare all persons who had been removed as deceased since the NDRI data download date with the matches derived from the NDRI. Details of any persons not removed were fed back to the relevant practices, which were given two months to identify any patients who appeared to be alive.
While Essex was able to automate, others resorted to manual methods for this task. Some are still at it.
NPfIT and data quality
Mr Shillington said variation between NHAIS sites was to be expected. “Populations also vary,” he said. “Some sites have a very transient population and therefore a more complex task.”
The NDRI did not take place in isolation, however. It was timed to have the maximum benefit for the National Programme for IT and the Information Quality Assurance Programme (IQAP), both of which have an interest in data quality, not least because the basic demographic data for the proposed national care record will come from GP lists.
It identified several lessons for this wider effort. For example, the system allows duplicate registrations for the same NHS number – an issue that the report says must be addressed in the new patient demographic system. Temporary NHS numbers are still in use; these will not be allowed in the new system.
The Audit Commission has fed these lessons back to NHS Connecting for Health and IQAP. But for some that’s not enough.
Paul Cundy, chair of the BMA and RCGP’s joint IT committee says: ‘This is not a new issue. GPs have been ghost busting for years. But it highlights precisely why you should not have a single record for everybody.”
An out of hours service or A&E department will not be able to find any “Micheals” or separate the Lawrences from the Laurances, he says. “That’s why we would prefer a system where the emphasis is on information beamed from place to place and matched by the person.”
Totally understood and accepted.
Solidgold
Herbie, there are some things JB can do about PPS:
1. Issue the clear statement about dividend. PPS speaks for credibility too.
2. Start issuing PRs which are more to the point.
3. Come out clear on all dark horses as much as possible.
3. Don't wait for questions to come, but show his awareness about competition and situation in general.
4. Upgrade the quality of his PRs.
5. Keep his loyal long shareholders interest in mind before making major decisions.
I bet he does! I remind him myself about PPS going down just in case if he doesn't have time to look at it.
And still no comments on dividends.
Jonathan's response on this:
Solidgold,
Very easy to deal with and we were with them at the National users group.
If you read the PR it states, secure remote access to patient notes for Doctors to "view" on the go and to book appointments. It does not state that the access is fully functional to allow updates and clinical consultation or submitting and recording data to the patient notes. There is the difference as MedifyRemote allows update, viewing and recording as if you were in the surgery, not just viewing.
Now if as stated in the PR 90 per cent would want access to view patient notes, how many would want access to view and up load to patient notes??????
This is extremely good news for us as it proves the market, proves the need via a third party and our product is better functionally and delivers more to the Doctors in my opinion. Also it does not state that the access to patient notes is accredited, nor approved through the National spine which I believe it is not. Hence the reason using this system you cannot update records during consultation remotely, you may only view. Thus this is just a dummy terminal or screen, not an functional extension of the EMIS system as MedifyRemote.
Thus in my opinion not a national solution which is the holy grail which is where MedifyRemote is headed.
This is absolute proof of Medify and also please note, we are delivering to the NHS as a whole not as a stand alone extension to a surgery system.
Jonathan
It was my thinking too. Check my post #8999.
Upcoming 2008 Democratic Convention agenda:
Old business - Bush bashing.
New business - Bush bashing.
Political platform - Bush bashing.
Political anthem - "What a wonderful day for Bush bashing" by
Sean Penn.
Good luck! Still nothing from Johny.
How about playing some on Clinton? Mr. or Mrs, or both. Thanks.
Hi Lem, congrats to you and other Eagles fans! Have fun and enjoy your mexican deportation. Just jocking and missing you already.
Solidgold
Yes, right after Larry Ellison.